Towards improved thrombolytic therapy
- 1 July 1993
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 342 (8862) , 34-36
- https://doi.org/10.1016/0140-6736(93)91888-s
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- THROMBOLYSIS: tPA fast by GUSTOThe Lancet, 1993
- Questions unresolved by the third international study of infarct survivalThe American Journal of Cardiology, 1992
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- Basic and clinical aspects of fibrinolysis and thrombolysisBlood, 1991
- Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.Circulation, 1991
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?Circulation, 1989
- Antibody-Directed Urokinase: A Specific Fibrinolytic AgentScience, 1985
- Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.Heart, 1985
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980